Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01747304
Other study ID # 12-0352
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 2012
Est. completion date December 2025

Study information

Verified date May 2023
Source University Health Network, Toronto
Contact Judite Scher, MSc CCRI
Phone 416-340-4841
Email jscher@uhnresearch.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

DXA scanners are routinely used to assess bone mineral density (BMD) and fracture risk in osteoporosis patients. They provide detailed bone imaging in a low radiation setting. Hologic manufactures scanners that are able to perform high definition instant vertebral fracture assessment (HD-IVA) used to screen at-risk patients for asymptomatic spine fractures instantly and reliably at the same time they are having their yearly BMD. We wish to investigate whether this same proven technology (HD-IVA scan mode) used on femurs (the scan mode is now called SE Femur scans) can be used to screen for atypical fractures of the femur in patients at risk for these debilitating fractures. In this proof of concept study, we propose to examine whether DXA scanners can provide a sensitive low radiation screening method to identify incomplete AFFs in patients with known incomplete AFFs and in patients at risk.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date December 2025
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: Known AFF group 1. A subject must have experienced an incomplete atypical low trauma fracture of the femoral shaft; 2. Is a patient at the UHN osteoporosis clinic. Comparison Group 1. Must be scheduled for a bone mineral density scan at UHN 2. Have been on any bisphosphonate for 5 years or longer, and; 3. Have unexplained symptoms of leg, hip, thigh, or knee pain. Exclusion Criteria: - There are no exclusions

Study Design


Intervention

Device:
DXA Se femur scans (previously called IVA femur)
Single Energy Beam (previously called inter-vertebral assessment) by Dual energy x-ray absorptiometry of affected femur

Locations

Country Name City State
Canada University Health Network Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary HD-IVA visualization of incomplete femur fractures Hologic DXA scanner using the high-definition IVA (HD-IVA) mode on femur bones will be able to visualize incomplete femur fractures at least 90% of the time in patients with known incomplete AFF. 1 day (one time point )
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04110795 - Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs
Recruiting NCT01747291 - Atypical Fracture Cohort Study
Recruiting NCT02150850 - Quebec Registry for Atypical Femur Fractures
Completed NCT01875458 - Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use